Executive Medical Director

Kaye/Bassman is partnering with a leading global biopharma on a high-visibility search for an Executive Medical Director to serve as Global Clinical Lead for a late-stage hematology asset.
The opportunity
Own clinical strategy for a Phase 3 program in myeloid malignancies, from pivotal execution through registration and toward launch
Lead the global development team across the US, EU, and Asia, and drive key go/no-go and labeling-critical decisions
Lead clinical science interactions with the FDA and other health authorities, including potential advisory committee preparation
Partner closely with Medical Affairs and senior commercial leadership
Report directly to the head of clinical development, with scope to expand into additional indications or earlier-stage programs, and a clear path toward VP
What you bring
MD or MD/PhD; U.S. clinical training preferred
10+ years in pharma research, including 7+ years in Phase I to IV clinical development
Phase 3 leadership in hematology or oncology, ideally in hematologic malignancies
Exposure to NDA/MAA submissions and regulatory interactions
Experience leading global, matrixed teams
Prior large pharma experience; exclusively start-up backgrounds are not a fit
Strong executive presence and the ability to influence senior clinical and commercial leaders